Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer

Chinese Journal of Pathology

Volumn 37, Issue 7, 2008, Pages 471-476

  Zhang, Bin ^a   Liu, Yan Xue ^b   Cao, Wen Feng ^b   Cao, Xu Chen ^b   Ning, Lian Sheng ^b   Hao, Xi Shan ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Breast neoplasms; Matrix metalloproteinase 13; Microarray analysis; Prognosis

Indexed keywords

BIOLOGICAL MARKER; COLLAGENASE 3; ESTROGEN RECEPTOR; GELATINASE A; GELATINASE B; PROGESTERONE RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER INVASION; CARCINOMA CELL; CYTOPLASM; FIBROBLAST; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; METASTASIS; ONCOGENE NEU; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR VOLUME; BREAST TUMOR; CANCER STAGING; CLASSIFICATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOPLASM INVASIVENESS; PATHOLOGY; PATHOPHYSIOLOGY;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 51249104682     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chinese source
2. Freije JM, Diez-Itza I, Balbin M, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem, 1994, 269(24):16766-16773.
3. Nielsen BS, Rank F, López JM, et al. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res, 2001, 61(19):7091-7100.
4. Balduyck M, Zerimech F, Gouyer V, et al. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis, 2000, 18(2):171-178.
5. Luukkaa M, Vihinen P, Kronqvist P, et al. Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. Head Neck, 2006, 28(3):225-234.
6. Johansson N, Vaalamo M, Grénman S, et al. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol, 1999, 154(2):469-480.
7. Boström PJ, Ravanti L, Reunanen N, et al. Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int J Cancer, 2000, 88(3): 417-423.
8. Etoh T, Inoue H, Yoshikawa Y, et al. Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness. Gut, 2000, 47(1):50-56.
9. Corte MD, Gonzalez LO, Corte MG, et al. Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma. Int J Biol Markers, 2005, 20(4):242-248.
10. O-Charoenrat P, Rhys-Evans PH, Eccles SA. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg, 2001, 127(7):813-820.
11. Charous SJ, Stricklin GP, Nanney LB, et al. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol, 1997, 106(4):271-278.
12. Vizoso FJ, González LO, Corte MD, et al. Study of matrix metalloproteinase and their inhibitors in breast cancer. Br J Cancer, 2007, 96(6):903-911.
13. Engelholm LH, Nielsen BS, Netzel-Arnett S, et al. The urokinase plasminogen activator receptor-associated protein/endo180 is coexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesis. Lab Invest, 2001, 81(10):1403-1414.
14. Cao W, Zhang B, Liu Y, et al. High-level SLP-2 expression and HER-2/neu protein expression are associated with decreased breast cancer patient survival. Am J Clin Pathol, 2007, 128(3):430-436.
15. Jinga DC, Blidaru A, Condrea I, et al. MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors. J Cell Mol Med, 2006, 10 (2):499-510.
16. Hornebeck W, Lambert E, Petitfrère E, et al. Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression. Biochimie, 2005, 87(3-4):377-383.
17. Würtz SO, Schrohl AS, Sørensen NM, et al. Tissue inhibitor of metalloproteinases-1 in breast cancer. Endocr Relat Cancer, 2005, 12(2):215-227.